Magnetic Capture of a Molecular Biomarker from Synovial Fluid in a Rat Model of Knee Osteoarthritis.

PubWeight™: 0.80^‹?›

🔗 View Article (PMID 26136062)

Published in Ann Biomed Eng on July 02, 2015

Authors

Elena G Yarmola¹^,2, Yash Shah¹, David P Arnold³^,4^,5, Jon Dobson¹^,6^,4^,5, Kyle D Allen⁷^,8^,9^,10

Author Affiliations

1: J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, 1275 Center Dr, Biomedical Sciences Building, JG56, Gainesville, FL, 32610, USA.
2: Department of Medicine, University of Florida, 1600 SW Archer Rd, Gainesville, FL, 32610, USA.
3: Department of Electrical and Computer Engineering, University of Florida, 216 Larsen Hall, Gainesville, FL, 32611, USA.
4: Institute for Cell Engineering and Regenerative Medicine, University of Florida, 300 Weil Hall, Gainesville, FL, 32611, USA.
5: Nanoscience Institute for Medical and Engineering Technology (NIMET), University of Florida, 1041 Center Dr, Gainesville, FL, 32611, USA.
6: Department of Materials Science and Engineering, University of Florida, 100 Rhines Hall, Gainesville, FL, 32611, USA.
7: J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, 1275 Center Dr, Biomedical Sciences Building, JG56, Gainesville, FL, 32610, USA. kyle.allen@bme.ufl.edu.
8: Institute for Cell Engineering and Regenerative Medicine, University of Florida, 300 Weil Hall, Gainesville, FL, 32611, USA. kyle.allen@bme.ufl.edu.
9: Nanoscience Institute for Medical and Engineering Technology (NIMET), University of Florida, 1041 Center Dr, Gainesville, FL, 32611, USA. kyle.allen@bme.ufl.edu.
10: Department of Biomedical Engineering, University of Florida, PO Box 116131, Gainesville, FL, 32611, USA. kyle.allen@bme.ufl.edu.

Associated clinical trials:

Study to Prevent Cartilage Damage Following Acute Knee Injury. | NCT00332254

Articles citing this ↘

Comparing intra-articular CTXII levels assessed via magnetic capture or lavage in a rat knee osteoarthritis model. Osteoarthritis Cartilage (2017) 0.75

Articles cited by this ↗

OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage (2010) 7.52

Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage (2005) 6.77

Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage (2006) 3.10

Inflammation in osteoarthritis. Curr Opin Rheumatol (2011) 2.72

Remote control of cellular behaviour with magnetic nanoparticles. Nat Nanotechnol (2008) 2.45

Magnetic nanoparticles for gene and drug delivery. Int J Nanomedicine (2008) 2.16

On the viscosity and pH of synovial fluid and the pH of blood. J Bone Joint Surg Br (1959) 2.03

Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage (2011) 1.89

Changes in serum and synovial fluid biomarkers after acute injury (NCT00332254). Arthritis Res Ther (2010) 1.61

Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria. Osteoarthritis Cartilage (2010) 1.44

Urea as a passive transport marker for arthritis biomarker studies. Arthritis Rheum (2002) 1.41

Protein traffic in human synovial effusions. Arthritis Rheum (1987) 1.28

Measurement of synovial fluid volume using urea. Osteoarthritis Cartilage (2007) 1.18

Biomarkers in osteoarthritis. Curr Opin Rheumatol (2005) 1.17

Kinematic and dynamic gait compensations resulting from knee instability in a rat model of osteoarthritis. Arthritis Res Ther (2012) 1.16

Lubrication of synovial membrane. Ann Rheum Dis (1971) 1.14

Recent advances in biomarkers in osteoarthritis. Curr Opin Rheumatol (2011) 1.09

The utility of measuring C-terminal telopeptides of collagen type II (CTX-II) in serum and synovial fluid samples for estimation of articular cartilage status in experimental models of destructive joint diseases. Osteoarthritis Cartilage (2006) 1.02

Development of superparamagnetic iron oxide nanoparticles (SPIONS) for translation to clinical applications. IEEE Trans Nanobioscience (2008) 0.94

Pharmacokinetics and pharmacodynamics of DPC 333 ((2R)-2-((3R)-3-amino-3{4-[2-methyl-4-quinolinyl) methoxy] phenyl}-2-oxopyrrolidinyl)-N-hydroxy-4-methylpentanamide)), a potent and selective inhibitor of tumor necrosis factor alpha-converting enzyme in rodents, dogs, chimpanzees, and humans. Drug Metab Dispos (2007) 0.93

Hyaluronic Acid (HA) Viscosupplementation on Synovial Fluid Inflammation in Knee Osteoarthritis: A Pilot Study. Open Orthop J (2013) 0.92

Summary of the OA biomarkers workshop 2010 - genetics and genomics: new targets in OA. Osteoarthritis Cartilage (2011) 0.92

Osteoarthritis year 2011 in review: biochemical markers of osteoarthritis: an overview of research and initiatives. Osteoarthritis Cartilage (2012) 0.82

Effect of exercise and osteochondral injury on synovial fluid and serum concentrations of carboxy-terminal telopeptide fragments of type II collagen in racehorses. Am J Vet Res (2010) 0.80

Associations of horse age, joint type, and osteochondral injury with serum and synovial fluid concentrations of type II collagen biomarkers in Thoroughbreds. Am J Vet Res (2010) 0.80

Assessing biomarkers in synovial fluid: consider the kinetics of clearance. Osteoarthritis Cartilage (2012) 0.80

Biochemical markers in synovial fluid identify early osteoarthritis of the glenohumeral joint. Clin Orthop Relat Res (1996) 0.80

Osteochondral injury increases type II collagen degradation products (C2C) in synovial fluid of Thoroughbred racehorses. Osteoarthritis Cartilage (2008) 0.77